Interestingly, in a murine model, rifaximin resulted in moderate reduction in HCC development in DEN-exposed animals via mechanisms involving intestinal microbiota and toll-like receptor 4 (TLR4) signaling [41]. Here, TLR4 is linked to hepatocellular carcinoma.